Article Versions Notes

Šisl D, Flegar D, Filipović M, Turčić P, Planinić P, Šućur A, Kovačić N, Grčević D, Kelava T. Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism. Biomedicines. 2022; 10(5):1209. https://doi.org/10.3390/biomedicines10051209

Šisl, Dino, Darja Flegar, Maša Filipović, Petra Turčić, Pavao Planinić, Alan Šućur, Nataša Kovačić, Danka Grčević, and Tomislav Kelava. 2022. "Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism" Biomedicines 10, no. 5: 1209. https://doi.org/10.3390/biomedicines10051209

Šisl, D., Flegar, D., Filipović, M., Turčić, P., Planinić, P., Šućur, A., Kovačić, N., Grčević, D., & Kelava, T. (2022). Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism. Biomedicines, 10(5), 1209. https://doi.org/10.3390/biomedicines10051209